Arvind Sood | Vice President of Investor Relations |
Bob Bradway | Chairman and Chief Executive Officer |
Murdo Gordon | Executive Vice President, Global Commercial Operations |
David Reese | Executive Vice President, Research and Development |
Peter Griffith | Chief Financial Officer |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Umer Raffat | Evercore ISI |
Chris Raymond | Piper Sandler |
Mohit Bansal | Wells Fargo |
Jay Olson | Oppenheimer |
Colin Bristow | UBS |
Brendan Smith | TD Cowen |
Robin Karnauskas | Truist Securities |
Gregory Renza | RBC Capital Markets |
Tim Anderson | Wolfe Research |
Geoff Meacham | Bank of America |
Dane Leone | Raymond James |
My name is Julianne and I'll be your conference facilitator today for Amgen's First Quarter Full Year 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speakers prepared remarks. [Operator Instructions]
I would now like to introduce Arvind Sood, Vice President of Investor Relations.